R
Rajesh Kumar
Researcher at Himachal Pradesh University
Publications - 6966
Citations - 180095
Rajesh Kumar is an academic researcher from Himachal Pradesh University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 149, co-authored 4439 publications receiving 140830 citations. Previous affiliations of Rajesh Kumar include Guru Nanak Dev University & Intuitive Surgical.
Papers
More filters
Journal ArticleDOI
Adverse reproductive and child health outcomes among people living near highly toxic waste water drains in Punjab, India
Jarnail Singh Thakur,Shankar Prinja,Dalbir Singh,Arvind Rajwanshi,Rajendra Prasad,Harjinder Kaur Parwana,Rajesh Kumar +6 more
TL;DR: Although no direct association could be established in this study, heavy metal and pesticide exposure may be potential risk factors for adverse reproductive and child health outcomes.
Journal ArticleDOI
Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo.
Aparna Singhal,Rajakumar Nagarajan,Charles H. Hinkin,Rajesh Kumar,James Sayre,Virginia Elderkin-Thompson,Amir Huda,Amir Huda,Rakesh K. Gupta,Steven-Huy B. Han,M. Albert Thomas +10 more
TL;DR: To evaluate regional cerebral metabolic and structural changes in patients with minimal hepatic encephalopathy (MHE) using two‐dimensional MR spectroscopy and T 1 ‐weighted MRI, to correlate the observed MR changes with neuropsychological (NP) test scores, and to compare the diagnostic accuracy of MRI, 2D MRS, and NP tests in discriminating between patients and healthy subjects.
Journal ArticleDOI
Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis: A Randomized Clinical Trial.
Rajesh Kumar,Sunil Dogra,Basant Amarji,Bhupinder Singh,Suresh Kumar,Sharma,Keshavamurthy Vinay,Rahul Mahajan,O. P. Katare +8 more
TL;DR: Topical liposomal formulation of cyclosporine, 2.0% w/w, is effective in treatment of limited chronic plaque psoriasis with a satisfactory safety profile and future clinical trials should assessliposomal cyclospora in larger study populations.
Journal ArticleDOI
Ag-Doped ZnO Nanoparticles for Enhanced Ethanol Gas Sensing Application.
TL;DR: The synthesized Ag-doped ZnO nanoparticles are grown in high density with an average diameter of ~20 ± 5 nm, possessing well-crystalline wurtzite hexagonal crystal structure and exhibiting good optical properties and gas response.
Journal ArticleDOI
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer
Thorunn Rafnar,Patrick Sulem,Gudmar Thorleifsson,Sita H. Vermeulen,Hannes Helgason,Jona Saemundsdottir,Sigurjon A. Gudjonsson,Asgeir Sigurdsson,Simon N. Stacey,Julius Gudmundsson,Hrefna Johannsdottir,Kristin Alexiusdottir,Vigdis Petursdottir,Sigfus Nikulasson,Gudmundur Geirsson,Thorvaldur Jonsson,Katja K.H. Aben,Anne J. Grotenhuis,Gerald W. Verhaegh,Aleksandra M. Dudek,J. Alfred Witjes,Antoine G. van der Heijden,Alina Vrieling,Tessel E. Galesloot,Ana de Juan,Angeles Panadero,Fernando Rivera,Carolyn D. Hurst,D. Timothy Bishop,Sei C. Sak,Ananya Choudhury,Mark Teo,Cecilia Arici,Angela Carta,Elena Toninelli,Petra J. de Verdier,Peter Rudnai,Eugene Gurzau,Kvetoslava Koppova,Kirstin A. van der Keur,Irene Lurkin,Mieke Goossens,Eliane Kellen,Simonetta Guarrera,Alessia Russo,Rossana Critelli,Carlotta Sacerdote,Paolo Vineis,Clémentine Krucker,Maurice P. Zeegers,Holger Gerullis,Daniel Ovsiannikov,Frank Volkert,Jan G. Hengstler,Silvia Selinski,Olafur T. Magnusson,Gisli Masson,Augustine Kong,Daniel F. Gudbjartsson,Annika Lindblom,Ellen C. Zwarthoff,Stefano Porru,Klaus Golka,Frank Buntinx,Frank Buntinx,Giuseppe Matullo,Rajesh Kumar,Jose I. Mayordomo,D. Gunnar Steineck,Anne E. Kiltie,Eirikur Jonsson,François Radvanyi,Margaret A. Knowles,Unnur Thorsteinsdottir,Unnur Thorsteinsdottir,Lambertus A. Kiemeney,Kari Stefansson,Kari Stefansson +77 more
TL;DR: Several correlated variants at 20p12, represented by rs62185668, show genome-wide significant association with UBC after combining discovery and replication results, adding to the growing number of UBC risk variants discovered through GWAS.